Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population

Atherosclerosis. 2010 Feb;208(2):305-16. doi: 10.1016/j.atherosclerosis.2009.06.005. Epub 2009 Jun 11.

Abstract

Epidemiological studies consistently demonstrate a strong inverse association between low levels of high-density lipoprotein (HDL) cholesterol and increased risk of ischemic heart disease (IHD). This review focuses on whether both rare and common genetic variation in ABCA1 contributes to plasma levels of HDL cholesterol and to risk of IHD in the general population, and further seeks to understand whether low levels of HDL cholesterol per se are causally related to IHD. Studies of the ABCA1 gene demonstrate a general strategy for detecting functional genetic variants, and show that both common and rare ABCA1 variants contribute to levels of HDL cholesterol and risk of IHD in the general population. The association between ABCA1 variants and risk of IHD appears, however, to be independent of plasma levels of HDL cholesterol. With the recent identification of the largest number of individuals heterozygous for loss-of-function mutations in ABCA1 worldwide, population studies suggests that genetically low HDL cholesterol per se does not predict an increased risk of IHD, and thus questions the causality of isolated low levels of HDL cholesterol for the development of IHD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters / genetics*
  • Alleles
  • Cholesterol, HDL / genetics*
  • Clinical Trials as Topic
  • Female
  • Genetic Variation*
  • Haplotypes
  • Heterozygote
  • Humans
  • Male
  • Models, Biological
  • Mutation*
  • Myocardial Ischemia / genetics*
  • Quantitative Trait Loci
  • Risk

Substances

  • ABCA1 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP-Binding Cassette Transporters
  • Cholesterol, HDL